title: Clinical pharmacology of cisplatin after intraperitoneal administration in patients with malignant ascites.
authors.affiliation: Institutes of Pharmacology, University of Verona, Italy.
authors.forename: M E
authors.initials: ME
authors.lastname: Fracasso
authors.forename: P
authors.initials: P
authors.lastname: Apostoli
authors.forename: G
authors.initials: G
authors.lastname: Benoni
authors.forename: A
authors.initials: A
authors.lastname: Bonetti
authors.forename: C
authors.initials: C
authors.lastname: Griso
authors.forename: R
authors.initials: R
authors.lastname: Leone
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D019540:Area Under Curve; D001201:Ascites / Q000188:drug therapy*; D002945:Cisplatin / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin